Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study

Diabetes Technology and Therapeutics

Volumn 18, Issue 3, 2016, Pages 127-135

  Picard, Sylvie ^a   Hanaire, Hélène ^b   Baillot Rudoni, Sabine ^c   Gilbert Bonnemaison, Elisabeth ^d   Not, Didier ^e   Reznik, Yves ^f   Guerci, Bruno ^g  

^a Point Medical   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE TOURS   (France)

^e Clinical Center   (France)

^f CAEN UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; PIG INSULIN; SHORT ACTING INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OBSERVATIONAL STUDY; PATIENT SATISFACTION; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; SENSOR AUGMENTED PUMP; ADOLESCENT; ADVERSE EFFECTS; AMBULATORY MONITORING; ANALYSIS; BLOOD; CHEMICALLY INDUCED; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 1; FRANCE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INCIDENCE; INSULIN INFUSION; MANPOWER; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; YOUNG ADULT;

EID: 84962597452     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2015.0240     Document Type: Article

References (30)

1. Raccah D, Sulmont V, Reznik Y, et al.: Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: The RealTrend study. Diabetes Care 2009;32:2245-2250.
2. Sulmont V, Lassmann-Vague V, Guerci B, et al.: Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001. Diabetes Metab 2011;37:59-63.
3. Lassmann-Vague V, Clavel S, Guerci B, et al.: When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009. Diabetes Metab 2010;36:79-85.
4. Benhamou PY, Catargi B, Delenne B, et al.: Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE. Diabetes Metab. 2012;38(Suppl 4): S67-S83.
5. Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271-286.
6. Tansey M, Laffel L, Cheng J, et al.: Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med 2011;28:1118-1122.
7. Hirsch IB: Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist. J Clin Endocrinol Metab 2009;94:2232-2238.
8. Nørgaard K, Scaramuzza A, Bratina N, et al.: Routine sensor-augmented pump therapy in type 1 diabetes: The INTERPRET study. Diabetes Technol Ther 2013;15:273-280.
9. Bergenstal RM, Tamborlane WV, Ahmann A, et al.: Sensoraugmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care 2011;34:2403-2405.
10. Moreno-Fernandez J, Gomez FJ, Gazquez M, et al.: Realtime continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study. Diabetes Technol Ther 2013;15:596-600.
11. Olivier P, Lawson ML, Huot C, et al.: Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy. J Diabetes Sci Technol 2014;8:523-528.
12. Schmidt S, Nørgaard K: Sensor-augmented pump therapy at 36 months. Diabetes Technol Ther 2012;14:1174-1177.
13. Chase HP, Beck RW, Xing D, et al.: Continuous glucose monitoring in youth with type 1 diabetes: 12-month followup of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther 2010;12:507-515.
14. Kordonouri O, Hartmann R, Pankowska E, et al.: Sensor augmented pump therapy from onset of type 1 diabetes: late follow-up results of the Pediatric Onset Study. Pediatr Diabetes 2012;13:515-518.
15. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, et al.: Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009;32:1947-1953.
16. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, et al.: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
17. Mauras N, Beck R, Xing D, et al.:Arandomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care 2012;35:204-210.
18. Peyrot M, Rubin RR; STAR 3 Study Group: Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial. Diabet Med 2013;30:464-467.
19. Slover RH, Welsh JB, Criego A, et al.: Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes 2012;13:6-11.
20. Bergenstal RM, Tamborlane WV, Ahmann A, et al.: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
21. Hermanides J, Nørgaard K, Bruttomesso D, et al.: Sensoraugmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med 2011;28:1158-1167.
22. Riveline JP, Schaepelynck P, Chaillous L, et al.: Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: A 1-year multicenter study. Diabetes Care 2012;35:965-971.
23. Battelino T, Phillip M, Bratina N, et al.: Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34:795-800.
24. Hirsch IB, Abelseth J, Bode BW, et al.: Sensor-augmented insulin pump therapy: results of the first randomized treatto-target study. Diabetes Technol Ther 2008;10:377-383.
25. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring ( JDRF-CGM) trial.Diabetes Care 2010;33:17-22.
26. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Lawrence JM, et al.: Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care 2010;33:2175-2177.
27. Polonsky WH, Hessler D: What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users. Diabetes Technol Ther 2013;15:295-301.
28. McQueen RB, Ellis SL, Maahs DM, et al.: Frequency of continuous glucose monitoring use and change in hemoglobin A1C for adults with type 1 diabetes in a clinical practice setting. Endocr Pract 2014;20:1007-1015.
29. Luijf YM, Mader JK, Doll W, et al.: Accuracy and reliability of continuous glucose monitoring systems: A head-to-head comparison. Diabetes Technol Ther 2013;15:722-727.
30. Heinemann L, Franc S, Phillip M, et al.: Reimbursement for continuous glucose monitoring: A European view. J Diabetes Sci Technol 2012;6:1498-1502.